Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.42 billion. The enterprise value is $1.43 billion.
| Market Cap | 1.42B |
| Enterprise Value | 1.43B |
Important Dates
The next confirmed earnings date is Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 46.76 million shares outstanding. The number of shares has increased by 2.31% in one year.
| Current Share Class | 46.76M |
| Shares Outstanding | 46.76M |
| Shares Change (YoY) | +2.31% |
| Shares Change (QoQ) | +0.92% |
| Owned by Insiders (%) | 1.80% |
| Owned by Institutions (%) | 102.51% |
| Float | 45.90M |
Valuation Ratios
The trailing PE ratio is 112.15 and the forward PE ratio is 17.14. Omnicell's PEG ratio is 3.55.
| PE Ratio | 112.15 |
| Forward PE | 17.14 |
| PS Ratio | 1.25 |
| Forward PS | 1.22 |
| PB Ratio | 1.13 |
| P/TBV Ratio | 5.41 |
| P/FCF Ratio | 9.36 |
| P/OCF Ratio | 7.54 |
| PEG Ratio | 3.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.75, with an EV/FCF ratio of 9.45.
| EV / Earnings | 114.05 |
| EV / Sales | 1.28 |
| EV / EBITDA | 22.75 |
| EV / EBIT | 260.33 |
| EV / FCF | 9.45 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.37 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 5.23 |
| Debt / FCF | 2.53 |
| Interest Coverage | 1.04 |
Financial Efficiency
Return on equity (ROE) is 1.03% and return on invested capital (ROIC) is 0.20%.
| Return on Equity (ROE) | 1.03% |
| Return on Assets (ROA) | 0.16% |
| Return on Invested Capital (ROIC) | 0.20% |
| Return on Capital Employed (ROCE) | 0.36% |
| Revenue Per Employee | $303,062 |
| Profits Per Employee | $3,414 |
| Employee Count | 3,670 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 6.41 |
Taxes
In the past 12 months, Omnicell has paid $13.06 million in taxes.
| Income Tax | 13.06M |
| Effective Tax Rate | 51.04% |
Stock Price Statistics
The stock price has increased by +13.58% in the last 52 weeks. The beta is 0.79, so Omnicell's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +13.58% |
| 50-Day Moving Average | 35.88 |
| 200-Day Moving Average | 40.29 |
| Relative Strength Index (RSI) | 33.52 |
| Average Volume (20 Days) | 644,383 |
Short Selling Information
The latest short interest is 2.21 million, so 4.74% of the outstanding shares have been sold short.
| Short Interest | 2.21M |
| Short Previous Month | 1.64M |
| Short % of Shares Out | 4.74% |
| Short % of Float | 4.82% |
| Short Ratio (days to cover) | 3.30 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.11 billion and earned $12.53 million in profits. Earnings per share was $0.27.
| Revenue | 1.11B |
| Gross Profit | 475.51M |
| Operating Income | 5.49M |
| Pretax Income | -20.77M |
| Net Income | 12.53M |
| EBITDA | 62.82M |
| EBIT | 5.49M |
| Earnings Per Share (EPS) | $0.27 |
Balance Sheet
The company has $369.20 million in cash and $382.55 million in debt, giving a net cash position of -$13.35 million or -$0.29 per share.
| Cash & Cash Equivalents | 369.20M |
| Total Debt | 382.55M |
| Net Cash | -13.35M |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 1.24B |
| Book Value Per Share | 26.81 |
| Working Capital | 219.82M |
Cash Flow
In the last 12 months, operating cash flow was $187.72 million and capital expenditures -$36.46 million, giving a free cash flow of $151.26 million.
| Operating Cash Flow | 187.72M |
| Capital Expenditures | -36.46M |
| Free Cash Flow | 151.26M |
| FCF Per Share | $3.23 |
Margins
Gross margin is 42.75%, with operating and profit margins of 0.49% and 1.13%.
| Gross Margin | 42.75% |
| Operating Margin | 0.49% |
| Pretax Margin | 2.30% |
| Profit Margin | 1.13% |
| EBITDA Margin | 5.65% |
| EBIT Margin | 0.49% |
| FCF Margin | 13.60% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.31% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.89% |
| FCF Yield | 10.68% |
Analyst Forecast
The average price target for Omnicell is $50.67, which is 67.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $50.67 |
| Price Target Difference | 67.39% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 15.20% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 2.03 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.03 |
| Piotroski F-Score | 5 |